Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, August 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 52 articles: HTML format

Single Articles

1. HARUTYUNOVA S, Heinz J, Benjamin N, Bruckner L, et al
   Effects of riociguat on right ventricular size and function in pulmonary arterial hypertension (RIVER II): a prospective, phase IV study.
   Respir Res. 2026;27:296.
   PubMed    
   Abstract available
   
   

2. OMUR SE, Zorlu C, Karayakali M, Karaman K, et al
   Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study.
   J Thromb Thrombolysis. 2026 Jul 31. doi: 10.1007/s11239-026-03375.
   PubMed    
   Abstract available
   
   

3. SHE W, She M, Sun T
   Comment on: 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study'.
   Eye (Lond). 2026 Jul 31. doi: 10.1038/s41433-026-04378.
   PubMed    
   
   
   

4. AYALASOMAYAJULA S, Bajwa EK, Cornell AG, Loureiro MJ, et al
   The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification.
   Clin Transl Sci. 2026;19:e70685.
   PubMed    
   Abstract available
   
   

5. LIANG J, Xie Y, Su D, Pang Y, et al
   Post-translational modification crosstalk in pulmonary arterial hypertension: mechanisms and therapeutic implications.
   Mol Biol Rep. 2026;53:1308.
   PubMed    
   Abstract available
   
   

6. WANG L, Cui Y, Song J, Zhao Q, et al
   Pseudo-Infarction Reversal in Right Precordial Leads: ECG Evolution in Severe Pulmonary Hypertension.
   JACC Case Rep. 2026;31:109342.
   PubMed    
   Abstract available
   
   

7. DUIJNHOUWER AL, Hagmolen Of Ten Have W, Van Haren-Willems J, Knaapen-Hans H, et al
   Apparent nonadherence to risk-guided therapy in pulmonary hypertension: The role of clinical complexity in real-world practice.
   Respir Med Res. 2026;90:101306.
   PubMed    
   Abstract available
   
   

8. KAMENSKI-RATHMANNER T, Tornyos A, Brcic L, Talakic E, et al
   Pulmonary hypertension in patients with moderate to severe hypersensitivity pneumonitis.
   Respiration. 2026 Jul 29:1-19. doi: 10.1159/000553575.
   PubMed    
   Abstract available
   
   

9. VILLANUEVA LM, Ito H, Qi X, Chapoval SP, et al
   Absence of insulin receptor substrate 2 (IRS2) in myeloid cells results in enhanced hypoxia-induced remodeling of the pulmonary vasculature and heart with modest effects on allergic lung inflammation.
   Immunohorizons. 2026;10:vlag028.
   PubMed    
   Abstract available
   
   

10. MOHIADDIN H, Mohee K, Ambrogetti R, Bhandari SS, et al
    Does severe pulmonary hypertension affect long-term survival after TAVI for severe aortic stenosis?
    Br J Cardiol. 2026;33:003.
    PubMed    
    Abstract available
    
    

11. YU Q, Zhao Y, Huang Y, Zhang M, et al
    Identification of pulmonary hypertension with pulmonary vascular surface volume ratio by non-contrast CT.
    BMC Cardiovasc Disord. 2026;26:641.
    PubMed    
    Abstract available
    
    

12. HUANG A, Pan T, Gao Y, Ji G, et al
    Construction of nomogram for predicting pulmonary hypertension on echocardiography in chronic obstructive pulmonary disease: a single-center retrospective study.
    Open Med (Wars). 2026;21:20261475.
    PubMed    
    Abstract available
    
    

13. JUMATATE R, Labaf A, Ingvarsson A, Johansson M, et al
    Right ventricular longitudinal function is associated with exercise capacity in pre-capillary pulmonary hypertension: a multimodality imaging study.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag116.
    PubMed    
    Abstract available
    
    

14. GHERBESI E, Faggiano A, Cuspidi C
    The Electrocardiogram and Pulmonary Hypertension: When Occam'S Razor Fails.
    Echocardiography. 2026;43:e70577.
    PubMed    
    
    
    

15. MICKAEL C, Fonseca Balladares DC, Kumar R, Lee MH, et al
    Role of CD4 T cell mannose binding lectin in Schistosoma-induced pulmonary hypertension.
    JCI Insight. 2026 Jul 28:e202919. doi: 10.1172/jci.insight.202919.
    PubMed    
    Abstract available
    
    

16. CHEN Z, Ge D, Li X, Wei TW, et al
    AMPK/USP10 loop activation of ACE2: implications for pulmonary hypertension.
    Eur Heart J. 2026 Jul 28:ehag568. doi: 10.1093.
    PubMed    
    Abstract available
    
    

17. LUO X, Xiong X, Li J, Luo J, et al
    The Level and Clinical Significance of Red Blood Cell Distribution Width in Patients With Congenital Heart Disease Associated With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70339.
    PubMed    
    Abstract available
    
    

18. YOGESWARAN A, Funderich M, Wendlandt K, Annis JS, et al
    Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD).
    Pulm Circ. 2026;16:e70348.
    PubMed    
    Abstract available
    
    

19. DAGHER C, Moallem N, Fiscus G, Carollo B, et al
    Noninvasive Gas Exchange Determinants of Exercise Hemodynamics in Non-Severe Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Pulm Circ. 2026;16:e70358.
    PubMed    
    Abstract available
    
    

20. SUZUKI Y, Nakano Y, Okazaki K, Ito M, et al
    Long-Term Supervised Cardiac Rehabilitation After Balloon Pulmonary Angioplasty Improved Residual Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Two-Case Report.
    Pulm Circ. 2026;16:e70359.
    PubMed    
    Abstract available
    
    

21. RAJAGOPAL S, Abueg J, Hart KM, Lau E, et al
    Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review.
    Pulm Circ. 2026;16:e70353.
    PubMed    
    Abstract available
    
    

22. REISER AE, Thiersch M, Gassmann M, Schneider SR, et al
    Iron Homeostasis at High Altitude in Patients With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70352.
    PubMed    
    Abstract available
    
    

23. MCGARRITY S, Johansson PI, Carlsen J
    Metabolic Markers as Potential Risk Factors in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70342.
    PubMed    
    Abstract available
    
    

24. YUE J, Wang P, Liu H, Pei H, et al
    Poncirin Alleviates Hypoxic Pulmonary Hypertension by Blocking TDP43-Mediated Macrophage Pyroptosis.
    Pulm Circ. 2026;16:e70368.
    PubMed    
    Abstract available
    
    

25. CHEN K, Li L, Huang Y, Ye L, et al
    The Role of Piezo Ion Channels in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70360.
    PubMed    
    Abstract available
    
    

26. KARIM R, Fyrdahl A, Ramos JG, Melin M, et al
    The Relationship Between Vortical Flow and Pressure Gradient Reversal in Pulmonary Hypertension-A 4D Analysis of Cardiovascular Magnetic Resonance Flow Imaging.
    Pulm Circ. 2026;16:e70350.
    PubMed    
    Abstract available
    
    

27. ALQARNI AA, Aljedani RH, Aldhahir AM, Alasimi AH, et al
    The Therapeutic Efficacy of Drugs Targeting the NO-sGC-cGMP Pathway in Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
    Pulm Circ. 2026;16:e70337.
    PubMed    
    Abstract available
    
    

28. RAWLINGS GH, Armstrong I, Thompson AR, Kiely DG, et al
    Getting the Wheels in Motion to Deal With Unmet Psychological Need: A Reply to "The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life".
    Pulm Circ. 2026;16:e70356.
    PubMed    
    
    
    

29. MOREL KC, Sood N, Bernardo R, Jackson K, et al
    Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management.
    Pulm Circ. 2026;16:e70340.
    PubMed    
    Abstract available
    
    

30. KARKOULIAS S, Leontsinis I, Iliakis P, Kallenou L, et al
    Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists.
    Medicina (Kaunas). 2026;62:1345.
    PubMed    
    Abstract available
    
    

31. HU L, Zhao Q, Zhao Z, Luo Q, et al
    Retrospective Evaluation of Recombinant Human Brain Natriuretic Peptide Therapy for Decompensated Right Heart Failure Across Pulmonary Hypertension Groups.
    Medicina (Kaunas). 2026;62:1213.
    PubMed    
    Abstract available
    
    

32. QI Y, Ma K, Han X, Xu D, et al
    Temporal Convolutional Neural Network Analysis of Magnetocardiography Signals for Detection of Pulmonary Hypertension.
    Bioengineering (Basel). 2026;13:736.
    PubMed    
    Abstract available
    
    

33. ZHONG D, Gao W, Ren J, Yang L, et al
    Vasoactive-Inotropic Score and in-hospital mortality in preterm infants < 34 weeks' gestation with early pulmonary hypertension in the setting of respiratory distress and sepsis.
    J Matern Fetal Neonatal Med. 2026;39:2705051.
    PubMed    
    Abstract available
    
    

34. TUTTLE M, Ruopp NF, Sarnak MJ
    Pulmonary Hypertension, Right Ventricular Remodeling and Outcomes in Chronic Kidney Disease.
    Clin J Am Soc Nephrol. 2026 Jul 27. doi: 10.2215/CJN.0000001198.
    PubMed    
    Abstract available
    
    

35. YE Y, Wang H, Lan Y, Pan W, et al
    Uric Acid-to-Albumin Ratio as a Complementary Biomarker for In-Hospital Risk Stratification in Patients with Pulmonary Hypertension: A Retrospective Cohort Study.
    J Cardiovasc Dev Dis. 2026;13:295.
    PubMed    
    Abstract available
    
    

36. HUANG C, Bai J, Luo A, Yang L, et al
    Omaveloxolone Driven NRF2 Activation as a Novel Therapeutic Strategy for Pulmonary Hypertension.
    Hypertension. 2026 Jul 27. doi: 10.1161/HYPERTENSIONAHA.126.26711.
    PubMed    
    Abstract available
    
    

37. NWOKEOCHA SO, Abduova L, Thiruvarudchelvam S, Chaudhary A, et al
    Pre-Capillary Pulmonary Hypertension in a Patient With Idiopathic Inflammatory Myopathy Without Extensive Pulmonary Involvement.
    Am J Case Rep. 2026;27:e953110.
    PubMed    
    Abstract available
    
    

38. KUCUK M, Zablah JE, Fleming G, Vanloozen D, et al
    Performance of the Occlutech(R) Atrial Flow Regulator Device in Patients With Either Failing Fontan Circulations or Irreversible Pulmonary Hypertension.
    Catheter Cardiovasc Interv. 2026 Jul 26. doi: 10.1002/ccd.70776.
    PubMed    
    Abstract available
    
    

39. GUIMARON S, Mercier J, Hautbergue T, Ruffenach G, et al
    Right ventricular remodeling and circulating metabolic profiles of patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy.
    JHLT Open. 2026;13:100618.
    PubMed    
    Abstract available
    
    

40. MUKHERJEE M, Hassoun PM
    Metabolism beyond mechanics: Revisiting right ventricular adaptation in pulmonary hypertension.
    J Nucl Cardiol. 2026;61:102792.
    PubMed    
    
    
    

41. LAMA E, Wang Y, Wu J, Ma Q, et al
    Pathophysiological mechanisms and therapeutic potential of E-selectin in pulmonary arterial hypertension.
    Front Immunol. 2026;17:1754940.
    PubMed    
    Abstract available
    
    

42. MERC P, Demir R, Zeren M, Durdu H, et al
    Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension.
    Turk J Med Sci. 2026;56:794-800.
    PubMed    
    Abstract available
    
    

43. LUO XY, Li XC, Fu X, Tian YY, et al
    Endoplasmic Reticulum Stress-Induced Endothelial Cell Pyroptosis Contributes to Pulmonary Vascular Remodeling and Pulmonary Arterial Hypertension via IRE1alpha/Caspase-3/GSDME Pathway.
    J Am Heart Assoc. 2026;15:e043577.
    PubMed    
    Abstract available
    
    

44. D'HUMIERES T, Jeune SL, de Luna G, Moulin T, et al
    The many facets of cardiopulmonary complications in sickle cell disease.
    Semin Hematol. 2026;63:16-27.
    PubMed    
    Abstract available
    
    

45. LU XT, Chen XR, Jin Q, Xu YY, et al
    Maternal and fetal outcomes in patients with congenital heart disease associated with pulmonary arterial hypertension in high-altitude areas: a retrospective cohort study.
    BMC Pregnancy Childbirth. 2026;26:818.
    PubMed    
    Abstract available
    
    

46. ZINELLU E, Piras B, Di Lorenzo B, Albrahimi E, et al
    A Retrospective Analysis of Risk Factors for Respiratory Failure in Silicosis Patients Exposed to Granite Dust.
    J Occup Environ Med. 2026;68:e560-e564.
    PubMed    
    Abstract available
    
    

47. DAGAN M, Nanayakkara S, Chan W, Beale A, et al
    Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment.
    Chest. 2026 Jul 28:S0012-3692(26)06312-9. doi: 10.1016/j.chest.2026.07.5215.
    PubMed    
    Abstract available
    
    

48. REDDY YNV, Frantz RP, Miranda WR, Harada T, et al
    Sotatercept in Pulmonary Arterial Hypertension: Central, Hematologic, and Peripheral Mechanisms of Benefit.
    J Am Coll Cardiol. 2026 Mar 2:S0735-1097(26)05633.
    PubMed    
    Abstract available
    
    

49. DOROBANTU DM, van de Bruaene A, Budts W, Cifra B, et al
    Sports and Supervised Exercise Programmes for Children and Young Adults with Pulmonary Hypertension. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) and the Association for European Paediatric and Conge
    J Heart Lung Transplant. 2026 Jul 29:S1053-2498(26)02015.
    PubMed    
    Abstract available
    
    

50. WU Y, Deng YR, Cui XP, Zhu SS, et al
    Misdiagnosed as Idiopathic PAH: Methylmalonic Acidemia as a Reversible Cause of Pediatric Pulmonary Hypertension.
    J Heart Lung Transplant. 2026 Jul 25:S1053-2498(26)02005.
    PubMed    
    Abstract available
    
    

51. PHAD N, Woodford R, de Waal K
    Left ventricular diastolic dysfunction in preterm infants with bronchopulmonary dysplasia.
    J Perinatol. 2026 Jun 1. doi: 10.1038/s41372-026-02715.
    PubMed    
    Abstract available
    
    

52. KUMAR U, Chiu S, Chia A, Varzaly J, et al
    Safety and efficacy of a dedicated pulmonary thromboendarterectomy fellowship: The Royal Papworth experience at a high-volume center.
    J Thorac Cardiovasc Surg. 2026;172:404-412.
    PubMed    
    Abstract available